Rep. Jefferson Shreve Sells Off Shares of Albemarle Co. (NYSE:ALB)

Representative Jefferson Shreve (R-Indiana) recently sold shares of Albemarle Co. (NYSE:ALB). In a filing disclosed on March 09th, the Representative disclosed that they had sold between $15,001 and $50,000 in Albemarle stock on February 24th. The trade occurred in the Representative’s “CRT – STANDARD UNIT TRUST” account.

Representative Jefferson Shreve also recently made the following trade(s):

  • Purchased $15,001 – $50,000 in shares of RTX (NYSE:RTX) on 2/24/2025.
  • Purchased $15,001 – $50,000 in shares of Royal Gold (NASDAQ:RGLD) on 2/24/2025.
  • Purchased $15,001 – $50,000 in shares of QUALCOMM (NASDAQ:QCOM) on 2/24/2025.
  • Purchased $15,001 – $50,000 in shares of Pfizer (NYSE:PFE) on 2/24/2025.
  • Sold $15,001 – $50,000 in shares of Norfolk Southern (NYSE:NSC) on 2/24/2025.
  • Purchased $15,001 – $50,000 in shares of CoStar Group (NASDAQ:CSGP) on 2/24/2025.
  • Purchased $50,001 – $100,000 in shares of AbbVie (NYSE:ABBV) on 2/24/2025.
  • Purchased $15,001 – $50,000 in shares of Johnson & Johnson (NYSE:JNJ) on 2/24/2025.
  • Purchased $15,001 – $50,000 in shares of The Cigna Group (NYSE:CI) on 2/24/2025.
  • Purchased $15,001 – $50,000 in shares of Adobe (NASDAQ:ADBE) on 2/24/2025.

Albemarle Stock Down 4.9 %

Shares of NYSE ALB traded down $3.77 on Tuesday, hitting $72.62. The company had a trading volume of 1,242,509 shares, compared to its average volume of 2,636,615. The business has a 50 day moving average of $83.73 and a two-hundred day moving average of $91.86. The firm has a market capitalization of $8.54 billion, a P/E ratio of -6.48 and a beta of 1.70. The company has a quick ratio of 1.19, a current ratio of 1.95 and a debt-to-equity ratio of 0.39. Albemarle Co. has a 12-month low of $67.23 and a 12-month high of $137.50.

Albemarle (NYSE:ALBGet Free Report) last issued its quarterly earnings data on Wednesday, February 12th. The specialty chemicals company reported ($1.09) EPS for the quarter, missing analysts’ consensus estimates of ($0.60) by ($0.49). Albemarle had a negative return on equity of 1.72% and a negative net margin of 21.93%. As a group, equities research analysts forecast that Albemarle Co. will post -0.04 earnings per share for the current fiscal year.

Albemarle Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, April 1st. Shareholders of record on Friday, March 14th will be paid a dividend of $0.405 per share. This represents a $1.62 dividend on an annualized basis and a dividend yield of 2.23%. The ex-dividend date is Friday, March 14th. Albemarle’s dividend payout ratio is presently -14.46%.

Wall Street Analysts Forecast Growth

ALB has been the subject of a number of research analyst reports. Truist Financial lowered their price target on Albemarle from $96.00 to $85.00 and set a “hold” rating for the company in a report on Friday, February 14th. Piper Sandler lowered their price objective on Albemarle from $90.00 to $85.00 and set an “underweight” rating for the company in a research note on Thursday, February 20th. Citigroup reduced their price target on shares of Albemarle from $115.00 to $85.00 and set a “neutral” rating for the company in a report on Wednesday, February 12th. Morgan Stanley cut their price objective on shares of Albemarle from $73.00 to $68.00 and set an “underweight” rating on the stock in a research report on Tuesday, February 18th. Finally, Clarkson Capital started coverage on shares of Albemarle in a research report on Tuesday, January 14th. They issued a “buy” rating and a $112.00 target price for the company. Two investment analysts have rated the stock with a sell rating, thirteen have issued a hold rating and six have issued a buy rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $107.05.

View Our Latest Report on ALB

Institutional Investors Weigh In On Albemarle

A number of institutional investors and hedge funds have recently modified their holdings of the business. Farther Finance Advisors LLC increased its stake in shares of Albemarle by 3.7% in the 3rd quarter. Farther Finance Advisors LLC now owns 2,832 shares of the specialty chemicals company’s stock valued at $268,000 after acquiring an additional 102 shares during the last quarter. TD Private Client Wealth LLC increased its stake in Albemarle by 50.4% during the 3rd quarter. TD Private Client Wealth LLC now owns 394 shares of the specialty chemicals company’s stock worth $37,000 after purchasing an additional 132 shares in the last quarter. MassMutual Private Wealth & Trust FSB lifted its stake in Albemarle by 48.9% in the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 414 shares of the specialty chemicals company’s stock valued at $36,000 after buying an additional 136 shares in the last quarter. First Community Trust NA boosted its holdings in shares of Albemarle by 55.0% in the fourth quarter. First Community Trust NA now owns 400 shares of the specialty chemicals company’s stock valued at $34,000 after buying an additional 142 shares during the period. Finally, Moser Wealth Advisors LLC increased its position in shares of Albemarle by 5.3% during the third quarter. Moser Wealth Advisors LLC now owns 2,925 shares of the specialty chemicals company’s stock worth $277,000 after acquiring an additional 146 shares in the last quarter. 92.87% of the stock is owned by institutional investors.

About Representative Shreve

Jefferson Shreve (Republican Party) is a member of the U.S. House, representing Indiana’s 6th Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027.

Shreve (Republican Party) is running for re-election to the U.S. House to represent Indiana’s 6th Congressional District. He declared candidacy for the 2026 election.

Email [email protected] to notify us of updates to this biography.
Jefferson Shreve earned a bachelor’s degree from Indiana University in 1989, a graduate degree from the University of London in 1998, and a graduate degree from Purdue University in 2003. Shreve’s career experience includes working as a real estate executive.

Shreve was elected 7th District Vice Chairman of the Indiana Republican State Committee on January 17, 2018, and was re-elected on March 6, 2021. In 2020, he was selected as a district-level delegate to the 2020 Republican National Convention.

Albemarle Company Profile

(Get Free Report)

Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Energy Storage, Specialties and Ketjen. The Energy Storage segment offers lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride; technical services for the handling and use of reactive lithium products; and lithium-containing by-products recycling services.

Recommended Stories

Receive News & Ratings for Albemarle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Albemarle and related companies with MarketBeat.com's FREE daily email newsletter.